Last reviewed · How we verify
Hypophosphatasia
Approved treatments
- Strensiq · AstraZeneca
Strensiq works by replacing the deficient tissue-nonspecific alkaline phosphatase enzyme in patients with hypophosphatasia.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Hypophosphatasia patent landscape — cliff calendar, originator estates, attackable patents
- Hypophosphatasia treatment landscape brief
- Hypophosphatasia treatment updates RSS
Frequently asked questions about Hypophosphatasia
What drugs treat Hypophosphatasia?
Tracked treatments include Strensiq.
What is the treatment for Hypophosphatasia?
Standard treatment for Hypophosphatasia includes Strensiq. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Hypophosphatasia patent cliff · Hypophosphatasia CI report
- Treatment: Strensiq · AstraZeneca
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing